Vitamin D supplementation to prevent tuberculosis infection in South African schoolchildren: multicenter phase 3 double-blind randomized placebo-controlled trial (ViDiKids)
Vitamin D supplementation to prevent tuberculosis infection in South African schoolchildren: multicenter phase 3 double-blind randomized placebo-controlled trial (ViDiKids)
复制标题
补充维生素 D 以预防南非学童的结核感染:多中心 3 期双盲随机安慰剂对照试验 (ViDiKids)
DOI:
10.1016/j.ijid.2023.05.010
复制
发表时间:
2023
影响因子:
8.4
通讯作者:
Middelkoop K
中科院分区:
文献类型:
--
作者:
Middelkoop K
ObjectivesTo determine whether weekly oral supplementation with 10,000 IU vitamin D3for 3 years reduces the risk of sensitization toM. tuberculosisin South African schoolchildren aged 6-11 years with negative QuantiFERON-tuberculosis (TB) Gold Plus (QFT-Plus) assay results at baseline.MethodsWe conducted a phase 3 randomized placebo-controlled trial in 1682 children attending 23 primary schools in Cape Town. The primary outcome was a positive end-trial QFT-Plus result, analyzed using a mixed effects logistic regression model with the school of attendance included as a random effect.Results829 vs. 853 QFT-Plus-negative children were randomized to receive vitamin D3vs. placebo, respectively. Mean end-study 25(OH)D concentrations in participants randomized to vitamin D vs. placebo were 104.3 vs 64.7 nmol/l, respectively (95% confidence interval for difference, 37.6 to 41.9 nmol/l). A total of 76/667 (11.4%) participants allocated to vitamin D vs. 89/687 (13.0%) participants allocated to placebo tested QFT-Plus positive at 3-year follow-up (adjusted odds ratio 0.86, 95% confidence interval 0.62-1.19,P= 0.35).ConclusionWeekly oral supplementation with 10,000 IU vitamin D3for 3 years elevated serum 25(OH)D concentrations among QFT-Plus-negative Cape Town schoolchildren but did not reduce their risk of QFT-Plus conversion.